Related Experiment Video
Updated: May 21, 2026
08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Menopausal hot flashes and insulin resistance
Pauliina Tuomikoski1, Olavi Ylikorkala, Tomi S Mikkola
1Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland.
Menopause (New York, N.Y.)
|June 7, 2012
Summary
Menopausal hot flashes did not correlate with insulin resistance in postmenopausal women. This suggests hot flashes may not directly impact cardiovascular health markers like insulin resistance. Further research is needed due to the small sample size.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Health
- Menopause Research
Background:
- Menopausal hot flashes are increasingly linked to cardiovascular health.
- Insulin resistance is a key marker for cardiovascular health.
- The relationship between hot flashes and insulin resistance in postmenopausal women requires investigation.
Purpose of the Study:
- To investigate the impact of hot flashes on insulin resistance in recently postmenopausal women.
- To determine if hot flash severity or frequency correlates with insulin resistance levels.
Main Methods:
- 143 healthy, normal-weight, recently postmenopausal women were studied.
- Hot flash frequency and severity were prospectively recorded and scored.
- Insulin resistance was assessed using the homeostasis model assessment (HOMA) from fasting blood samples.
Main Results:
- No significant differences in glucose, insulin, or HOMA levels were found across hot flash severity groups.
- Insulin resistance was not associated with the number or severity of hot flashes.
- Insulin resistance positively correlated with body mass index and negatively with estradiol levels.
Conclusions:
- Insulin resistance does not appear to be directly involved in hot flash-related cardiovascular changes.
- These findings suggest hot flashes may not be a direct indicator of insulin resistance in this population.
- The study's small sample size necessitates cautious interpretation of the results.
Related Concept Videos
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...